Medicare Enrolled
Dr. Madhavi Mummaneni, MD
Hematology & Oncology · Orange, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mummaneni from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mummaneni?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mummaneni
Dr. Madhavi Mummaneni is a hematology & oncology specialist in Orange, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mummaneni performed 6,916 Medicare services across 712 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mummaneni received a total of $27,291 from 101 pharmaceutical and/or device companies across 1521 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mummaneni is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 31% volume in CA
$27,291 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,916
Medicare services
Top 31% in CA for hematology & oncology
712
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~364 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 3,240 | $19 | $75 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
1,560 | $6 | $24 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
665 | $103 | $375 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
569 | $8 | $38 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
555 | $8 | $17 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
113 | $12 | $48 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
95 | $10 | $32 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
43 | $66 | $217 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
30 | $78 | $285 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
30 | $64 | $247 |
| New patient office visit, complex (60-74 min) | 16 | $177 | $689 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$27,291
Total received (2018-2024)
Avg $3,899/year across 7 years
Top 16% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
101
Companies
1,521
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$27,028 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$264 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,170
2023
$4,582
2022
$4,872
2021
$3,448
2020
$2,585
2019
$3,538
2018
$3,097
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$568
PFIZER INC.
$439
Merck Sharp & Dohme LLC
$248
AstraZeneca Pharmaceuticals LP
$246
GlaxoSmithKline, LLC.
$244
Exelixis Inc.
$241
Celgene Corporation
$237
Janssen Biotech, Inc.
$227
Eisai Inc.
$196
E.R. Squibb & Sons, L.L.C.
$189
Alexion Pharmaceuticals, Inc.
$181
ABBVIE INC.
$175
Gilead Sciences, Inc.
$164
Daiichi Sankyo Inc.
$153
Takeda Pharmaceuticals U.S.A., Inc.
$139
ARRAY BIOPHARMA INC
$135
PharmaEssentia USA Corporation
$130
PUMA BIOTECHNOLOGY, INC.
$105
Astellas Pharma US Inc
$104
Incyte Corporation
$96
Karyopharm Therapeutics Inc.
$94
Stemline Therapeutics Inc.
$89
Sumitomo Pharma America, Inc.
$78
SOBI, INC
$74
Regeneron Healthcare Solutions, Inc.
$68
GENZYME CORPORATION
$61
SpringWorks Therapeutics, Inc.
$56
Genentech USA, Inc.
$52
Blueprint Medicines Corporation
$50
Rigel Pharmaceuticals, Inc.
$42
Pharmacosmos Therapeutics Inc.
$32
Genmab U.S., Inc.
$30
BeiGene USA, Inc.
$29
Lilly USA, LLC
$27
Immunocore Limited
$26
Ipsen Biopharmaceuticals, Inc
$25
ACCORD HEALTHCARE, INC.
$24
ADC Therapeutics America, Inc.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
TAIHO ONCOLOGY, INC.
$17
Acrotech Biopharma Inc.
$16
Agios Pharmaceuticals, Inc.
$16
EMD Serono, Inc.
$13
Top 3 companies account for 24.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$2,167
Amgen Inc.
$1,992
E.R. Squibb & Sons, L.L.C.
$1,653
AstraZeneca Pharmaceuticals LP
$1,629
Celgene Corporation
$1,377
PFIZER INC.
$1,241
Merck Sharp & Dohme Corporation
$1,060
Genentech USA, Inc.
$1,025
Merck Sharp & Dohme LLC
$940
Seagen Inc.
$901
Exelixis Inc.
$874
Pharmacyclics LLC, An AbbVie Company
$679
Incyte Corporation
$665
Eisai Inc.
$563
Janssen Biotech, Inc.
$537
Daiichi Sankyo Inc.
$513
Takeda Pharmaceuticals U.S.A., Inc.
$501
Gilead Sciences, Inc.
$465
GlaxoSmithKline, LLC.
$434
BeiGene USA, Inc.
$421
ABBVIE INC.
$407
Bayer HealthCare Pharmaceuticals Inc.
$385
Astellas Pharma US Inc
$380
EISAI INC.
$349
GENZYME CORPORATION
$329
PUMA BIOTECHNOLOGY, INC.
$268
Alexion Pharmaceuticals, Inc.
$253
Boehringer Ingelheim Pharmaceuticals, Inc.
$228
Karyopharm Therapeutics Inc.
$224
Foundation Medicine, Inc.
$217
ARRAY BIOPHARMA INC
$217
Regeneron Healthcare Solutions, Inc.
$214
Aurobindo Pharma USA, Inc.
$180
Kite Pharma, Inc.
$174
TerSera Therapeutics LLC
$166
Blueprint Medicines Corporation
$161
Pharmacyclics LLC, an AbbVie Company
$152
EMD Serono, Inc.
$146
Coherus Biosciences Inc.
$143
Myovant Sciences Inc.
$132
PharmaEssentia USA Corporation
$130
Stemline Therapeutics Inc.
$126
Seattle Genetics, Inc.
$125
Lilly USA, LLC
$119
Genmab U.S., Inc.
$113
Rigel Pharmaceuticals, Inc.
$112
Clovis Oncology, Inc.
$102
AbbVie, Inc.
$99
AbbVie Inc.
$98
Puma Biotechnology, Inc.
$85
Epizyme, Inc.,
$84
Deciphera Pharmaceuticals Inc.
$82
Sumitomo Pharma America, Inc.
$78
SOBI, INC
$74
Jazz Pharmaceuticals Inc.
$72
Pharmacosmos Therapeutics Inc.
$71
Otsuka America Pharmaceutical, Inc.
$69
Acceleron Pharma, Inc.
$68
MEDIVATION FIELD SOLUTIONS LLC
$67
AMAG Pharmaceuticals, Inc.
$67
Ipsen Biopharmaceuticals, Inc
$59
Helsinn Therapeutics (U.S.), Inc.
$57
SpringWorks Therapeutics, Inc.
$56
EUSA Pharma (US) LLC
$54
Dova Pharmaceuticals
$52
Servier Pharmaceuticals LLC
$44
Alnylam Pharmaceuticals Inc.
$43
Agios Pharmaceuticals, Inc.
$41
Lexicon Pharmaceuticals, Inc.
$37
AVEO Pharmaceuticals, Inc.
$35
Bayer Healthcare Pharmaceuticals Inc.
$34
ADC Therapeutics America, Inc.
$34
MorphoSys, US Inc.
$34
Spectrum Pharmaceuticals Inc.
$34
Janssen Scientific Affairs, LLC
$26
Immunocore Limited
$26
Heron Therapeutics, Inc.
$25
JAZZ PHARMACEUTICALS INC.
$25
ACCORD HEALTHCARE, INC.
$24
Blue Earth Diagnostics Limited
$24
Acrotech Biopharma LLC
$24
Genentech, Inc.
$24
Aveo Pharmaceuticals, Inc.
$22
Lantheus Medical Imaging, Inc.
$21
Sirtex Medical Inc
$17
TAIHO ONCOLOGY, INC.
$17
Mylan Institutional Inc.
$16
Emmaus Medical, Inc.
$16
Taiho Oncology, Inc.
$16
Medtronic USA, Inc.
$16
Acrotech Biopharma Inc.
$16
Apellis Pharmaceuticals, Inc.
$14
Mirati Therapeutics, Inc.
$14
Kyowa Kirin, Inc.
$14
CSL Behring
$13
Sobi, Inc
$13
SANOFI-AVENTIS U.S. LLC
$12
TESARO, Inc.
$12
CTI BioPharma Corp.
$12
Janssen Pharmaceuticals, Inc
$12
Secura Bio, Inc.
$6
Top 3 companies account for 21.3% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Actemra · Afstyla · Alecensa · Aliqopa · Aranesp · Avastin · Axumin · BALVERSA · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CAMCEVI · CARVYKTI · CHANTIX · CINVANTI · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELZONRIS · EMEND · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Empaveli · Endari · Enhertu · Epkinly · Erleada · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · Folotyn · Fulphila · GAMIFANT · GARDASIL · GAUCHER-DISEASE · GAZYVA · GILOTRIF · GIVLAARI · HEMADY · Halaven · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · Imbruvica · Inrebic · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · KYPHON Balloon Kyphoplasty · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POLIVY · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · Quadramet · Quzyttir · REBLOZYL · RETACRIT · RETEVMO · RYBREVANT · RYDAPT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYNAGIS · Stellant · Stivarga · Sylvant · TAFINLAR · TAGRISSO · TALVEY · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tecentriq · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Vanflyta · Vectibix · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XERMELO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
243
Per 100K population
7.7
County median income
$113,702
Nearest hospital
PROVIDENCE ST. JOSEPH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mummaneni is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 16% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mummaneni experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Mummaneni performed 3,240 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mummaneni receive payments from pharmaceutical companies?
Yes. Dr. Mummaneni received a total of $27,291 from 101 companies across 1,521 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mummaneni's costs compare to other hematology & oncology specialists in Orange?
Dr. Mummaneni's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mummaneni) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Orange
Browse hematology & oncology specialists in Orange ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology